 |
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Monday, May 20, 2013
|
|
|
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Monday, May 20, 2013
|
| Home | HealthTopics | Health Centers | Reference Library | Research |
 Join us on Facebook
|
Share on Facebook | Tweet |
|
Pharmacy and Medications |
Use of TB Medication in Early Pregnancy11/06/2009 |
I am a 34 years old woman. I was treated hystroscopy and D & C on 09 sep. 2009. The endometrial TB was detected in subsequent TB-PCR test and medication for management of Endometrial TB (AKT-4)were started on 15 Sep. 2009. On 30 oct. 2009 I discovered through home pregnancy test and scan that I was five weeks pregnant.Can you please answer the that is it safe to take AKT-4 in pregnancy for the baby. Please respond ASAP.........
Your medication AKT-4 consists of rifampin, isoniazid, pyrazinamide, and ethambutol. All four of these medications are recommended for treatment of TB in pregnancy. These medications should not harm the baby. It is important to continue your therapy even though you are pregnant.
|
Debra K Gardner, PhamD Former Assistant Clinical Professor of Pharmacy College Business Office Internal Resource Pool-Allied at OSU Medical Center Wexner Medical Center The Ohio State University |
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|